Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass

Biomaterials

Volumn 26, Issue 19, 2005, Pages 4171-4179

  Keshaw, Hussila ^a,b   Forbes, Alastair ^b   Day, Richard M ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Alginate; Angiogenesis; Boactive glass; Growth factors

Indexed keywords

BIOMATERIALS; CHARGE COUPLED DEVICES; GENES; GLASS; GROWTH KINETICS; OPTIMIZATION; PARTICLE SIZE ANALYSIS;

ANGIOGENIC GROWTH FACTORS; BIOACTIVE GLASS; CELL ENCAPSULATION; FIBROBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

CELLS;

ALGINIC ACID; ANGIOGENIC FACTOR; GLASS; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ENCAPSULATION; CELL PROLIFERATION; COMPARATIVE STUDY; CULTURE MEDIUM; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MEASUREMENT; MICROVASCULARIZATION; PRIORITY JOURNAL;

ALGINATES; BIOREACTORS; CELL CULTURE TECHNIQUES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; ENDOTHELIAL CELLS; FIBROBLASTS; GLASS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 12344263876     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.10.021     Document Type: Article

References (45)

1. M. Simons, and J.A. Ware Therapeutic angiogenesis in cardiovascular disease Nat Rev Drug Discov 2 2003 863 871
2. N. Ferrara Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am J Physiol Cell Physiol 280 2001 C1358 C1366
3. S. Banai, M.T. Jaklitsch, M. Shou, D.F. Lazarous, M. Scheinowitz, S. Biro, S.E. Epstein, and E.F. Unger Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs Circulation 89 1994 2183 2189
4. J.D. Pearlman, M.G. Hibberd, M.L. Chuang, K. Harada, J.J. Lopez, S.R. Gladstone, M. Friedman, F.W. Sellke, and M. Simons Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis Nat Med 1 1995 1085 1089
5. K. Harada, M. Friedman, J.J. Lopez, S.Y. Wang, J. Li, P.V. Prasad, J.D. Pearlman, E.R. Edelman, F.W. Sellke, and M. Simons Vascular endothelial growth factor administration in chronic myocardial ischemia Am J Physiol 270 1996 H1791 1802
6. J.J. Lopez, R.J. Laham, A. Stamler, J.D. Pearlman, S. Bunting, A. Kaplan, J.P. Carrozza, F.W. Sellke, and M. Simons VEGF administration in chronic myocardial ischemia in pigs Cardiovasc Res 40 1998 272 281
7. M.D. Hariawala, J.R. Horowitz, D. Esakof, D.D. Sheriff, D.H. Walter, B. Keyt, J.M. Isner, and J.F. Symes VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts J Surg Res 63 1996 77 82
8. T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, M. Simons, D.W. Losordo, R.C. Hendel, R.O. Bonow, S.M. Eppler, T.F. Zioncheck, E.B. Holmgren, and E.R. McCluskey Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease Am Heart J 142 2001 872 880
9. R.C. Hendel, T.D. Henry, K. Rocha-Singh, J.M. Isner, D.J. Kereiakes, F.J. Giordano, M. Simons, and R.O. Bonow Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion evidence for a dose-dependent effect Circulation 101 2000 118 121
10. J.F. Symes, D.W. Losordo, P.R. Vale, K.G. Lathi, D.D. Esakof, M. Mayskiy, and J.M. Isner Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease Ann Thorac Surg 68 1999 830 836
11. T.K. Rosengart, L.Y. Lee, S.R. Patel, T.A. Sanborn, M. Parikh, G.W. Bergman, R. Hachamovitch, M. Szulc, P.D. Kligfield, P.M. Okin, R.T. Hahn, R.B. Devereux, M.R. Post, N.R. Hackett, T. Foster, T.M. Grasso, M.L. Lesser, O.W. Isom, and R.G. Crystal Angiogenesis gene therapy phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease Circulation 100 1999 468 474
12. D.W. Losordo, P.R. Vale, R.C. Hendel, C.E. Milliken, F.D. Fortuin, N. Cummings, R.A. Schatz, T. Asahara, J.M. Isner, and R.E. Kuntz Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia Circulation 105 2002 2012 2018
13. T.D. Henry, B.H. Annex, G.R. McKendall, M.A. Azrin, J.J. Lopez, F.J. Giordano, P.K. Shah, J.T. Willerson, R.L. Benza, D.S. Berman, C.M. Gibson, A. Bajamonde, A.C. Rundle, J. Fine, and E.R. McCluskey VIVA Investigators. The VIVA trial Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis Circulation 107 2003 1359 1365
14. F.D. Fortuin, P. Vale, D.W. Losordo, J. Symes, G.A. DeLaria, J.J. Tyner, G.L. Schaer, R. March, R.J. Snell, T.D. Henry, J. Van Camp, J.J. Lopez, W. Richenbacher, J.M. Isner, and R.A. Schatz One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients Am J Cardiol 92 2003 436 439
15. Ye Lei, Kh Haider Husnain, Shujia Jiang, and S.K. Sim Eugene Therapeutic angiogenesis. Devising new strategies based on past experiences Basic Res Cardiol 99 2004 121 132
16. S.E. Epstein, R. Kornowski, S. Fuchs, and H.F. Dvorak Angiogenesis therapy amidst the hype, the neglected potential for serious side effects Circulation 104 2001 115 119
17. N. Ferrara, and K. Alitalo Clinical applications of angiogenic growth factors and their inhibitors Nat Med 12 1999 1359 1364
18. T.D. Henry Therapeutic angiogenesis BMJ 318 1999 1536 1539
19. L.L. Hench, R. Splinter, W. Allen, and T. Greenlee Bonding mechanisms at the interface of ceramic prosthestic materials J Biomed Mater Res 2 1971 117 141
20. L.L. Hench Bioceramics. J Am Ceram Soc 81 1998 1705 1728
21. T. Livingston, P. Ducheyne, and J. Garino In vivo evaluation of a bioactive scaffold for bone tissue engineering J Biomed Mater Res 62 2002 1 13
22. Day R. Bioglass® stimulates the secretion of angiogenic growth factors and angiogenesis. Tissue Eng 2005, in press.
23. R. Day, A.R. Boccaccini, S. Shurey, J.A. Roether, A. Forbes, L.L. Hench, and S.M. Gabe Assessment of polyglycolic acid mesh and bioactive glass for soft tissue engineering scaffolds Biomaterials 25 2004 5857 5866
24. S.R. Winn, P.A. Tresco, B. Zielinski, L.A. Greene, C.B. Jaeger, and P. Aebischer Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells Exp Neurol 113 1991 322 329
25. Y. Sun, X. Ma, D. Zhou, I. Vacek, and A.M. Sun Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression J Clin Invest 98 1996 1417 1422
26. J.M. Van Raamsdonk, C.J. Ross, M.A. Potter, S. Kurachi, K. Kurachi, D.W. Stafford, and P.L. Chang Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics J Lab Clin Med 139 2002 35 42
27. S. Thomas Alginate dressings in surgery and wound management - Part 1 J Wound Care 9 2000 56 60
28. A.H. Cory, T.C. Owen, J.A. Barltrop, and J.G. Cory Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture Cancer Commun 3 1991 207 212
29. M.J. Allen, and N. Rushton Use of the CytoTox 96™ Assay in routine biocompatibility testing in vitro Promega Notes 45 1994 7 10
30. M. Bellantone, H.D. Williams, and L.L. Hench Broad-spectrum bactericidal activity of Ag(2)O-doped bioactive glass Antimicrob Agents Chemother 466 2002 1940 1945
31. M.C. Peters, B.C. Isenberg, J.A. Rowley, and D.J. Mooney Release from alginate enhances the biological activity of vascular endothelial growth factor J Biomater Sci Polym Ed 9 1998 1267 1278
32. F. Gu, B. Amsden, and R. Neufeld Sustained delivery of vascular endothelial growth factor with alginate beads J Control Release 96 2004 463 472
33. Y.M. Elçin, V. Dixit, and G. Gitnick Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor implications for tissue engineering and wound healing Artif Organs 25 2001 558 565
34. Y. Dor, V. Djonov, R. Abramovitch, A. Itin, G.I. Fishman, P. Carmeliet, G. Goelman, and E. Keshet Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy EMBO J 21 2002 1939 1947
35. R. Khurana, and M. Simons Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease Trends Cardiovasc Med 13 2003 116 1122
36. A. Schultz, L. Lavie, I. Hochberg, R. Yar, T. Stone, K. Skorecki, P. Lavie, A. Roguin, and A.P. Levy Interindividual heterogeneity in the hypoxic regulation of VEGF significance for the development of the coronary artery collateral circulation Circulation 100 1999 547 552
37. H.M. Blau, and A. Banfi The well-tempered vessel Nat Med 7 2001 532 534
38. N. Chinen, M. Tanihara, M. Nakagawa, K. Shinozaki, E. Yamamoto, Y. Mizushima, and Y. Suzuki Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release J Biomed Mater Res 67A 2003 61 68
39. A. Perets, Y. Baruch, F. Weisbuch, G. Shoshany, G. Neufeld, and S. Cohen Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres J Biomed Mater Res 65A 2003 489 497
40. D. Chicheportiche, and G. Reach In vitro kinetics of insulin release by microencapsulated rat islets effect of the size of the microcapsules Diabetologia 31 1988 54 57
41. T. Visted, T. Furmanek, P. Sakariassen, W.B. Foegler, K. Sim, H. Westphal, R. Bjerkvig, and M. Lund-Johansen Prospects for delivery of recombinant angiostatin by cell-encapsulation therapy Hum Gene Ther 14 2003 1429 1440
42. S. Soker, M. Machado, and A. Atala Systems for therapeutic angiogenesis in tissue engineering World J Urol 18 2000 10 18
43. G. O'Toole, D. MacKenzie, M.F. Buckley, R. Lindeman, and M. Poole A review of therapeutic angiogenesis and consideration of its potential applications to plastic and reconstructive surgery Br J Plast Surg 54 2001 1 7
44. M.K. Jones, H. Kawanaka, D. Baatar, I.L. Szabo, K. Tsugawa, R. Pai, G.Y. Koh, I. Kim, I.J. Sarfeh, and A.S. Tarnawski Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1 Gastroenterology 121 2001 1040 1047
45. M. Galeano, B. Deodato, D. Altavilla, G. Squadrito, P. Seminara, H. Marini, F. StagnoD'Alcontres, M. Colonna, M. Calo, P. Lo Cascio, V. Torre, M. Giacca, F.S. Venuti, and F. Squadrito Effect of recombinant adeno-associated virus vectormediated vascular endothelial growth factor gene transfer on wound healing after burn injury Crit Care Med 31 2003 1017 1025